Your browser doesn't support javascript.
loading
A Case of Advanced Hepatocellular Carcinoma with Portal Vein Tumor Invasion that Showed Favorable Prognosis after Combined External Radiation Therapy and Sorafenib Therapy
Journal of Liver Cancer ; : 134-138, 2016.
Artigo em Coreano | WPRIM | ID: wpr-76008
ABSTRACT
A prognosis of hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) is dismal that the median survival is 2 to 4 months without treatment. Sorafenib, the standard regimen of advanced HCC, can prolong median survival only 1.5 months. A 50-year-old man with a history of chronic hepatitis B was diagnosed advanced HCC with PVTT. By a multidisciplinary medical team approach, the combination of 3-demensional conformal radiation therapy with sequential sorafenib was challenged. 4 months after initiation of treatment, he achieved partial response as modified response evaluation criteria in solid tumors criteria. Sorafenib was continued so far, and stable disease has been maintained up to now, without significant adverse effect.
Assuntos

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Veia Porta / Prognóstico / Trombose / Carcinoma Hepatocelular / Hepatite B Crônica / Critérios de Avaliação de Resposta em Tumores Sólidos Tipo de estudo: Estudo prognóstico Limite: Humanos Idioma: Coreano Revista: Journal of Liver Cancer Ano de publicação: 2016 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Veia Porta / Prognóstico / Trombose / Carcinoma Hepatocelular / Hepatite B Crônica / Critérios de Avaliação de Resposta em Tumores Sólidos Tipo de estudo: Estudo prognóstico Limite: Humanos Idioma: Coreano Revista: Journal of Liver Cancer Ano de publicação: 2016 Tipo de documento: Artigo